Follow-Up Appointments: Regular appointments are essential for monitoring your progress, managing side effects, and making any necessary adjustments to your treatment plan
As with any peptide, it is advisable to consult with a healthcare professional before initiating use.
Patients should contact their GP, NHS 111, or healthcare provider if they experience any of the following: Severe or worsening itching that does not improve with simple measures or persists for more than 4872 hours Extensive redness, swelling, or warmth at the injection site, which may indicate cellulitis or another bacterial skin infection Development of a rash that spreads beyond the immediate injection site, particularly if accompanied by systemic symptoms Pain or tenderness that is disproportionate to the expected discomfort from a subcutaneous injection Discharge, pus, or bleeding from the injection site, suggesting possible infection or abscess formation Fever, chills, or malaise occurring in conjunction with injection site symptoms, which may indicate systemic infection or hypersensitivity Signs of a serious allergic reaction require immediate emergency attention
Waist circumference reduction: Tirzepatide reduced waist circumference by an average of 18.4 cm versus 13.0 cm with semaglutide a meaningful difference for cardiometabolic risk
Neither is definitively bettertheir complementary roles in reducing oxidative stress make them effective allies for health, whether used separately or together, depending on your wellness goals
